Can I read Iimy 17 2464528 on EtoBox?

Iimy 17 2464528 by muhammadanas9704 is a document available to read on EtoBox.

What is Iimy 17 2464528 about?

The ROCKET program is a phase 3 clinical trial evaluating the efficacy and safety of rocatinlimab, a T-cell rebalancing therapy targeting the OX40 receptor, in patients with moderate-to-severe atopic dermatitis (AD). This comprehensive program includes eight trials assessing rocatinlimab as both monotherapy and in combination with topical treatments, aiming to provide robust data on its effectiveness and long-term safety. Results from these trials are expected between 2024 and 2027, addressing the unmet nee

Author

muhammadanas9704

Language

EN